TrialDiabetes, obesity & metabolism2019

Low doses of dasiglucagon consistently increase plasma glucose levels from hypoglycaemia and euglycaemia in people with type 1 diabetes mellitus.

Ulrike Hövelmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.